article thumbnail

Gepirone

New Drug Approvals

However, in 2012 it once again failed to convince the FDA of its qualities for treating anxiety and depression. [5] 5] In December 2015, the FDA once again gave gepirone a negative review for depression due to concerns of efficacy. [12] 12] However, in March 2016, the FDA reversed its decision and gave gepirone ER a positive review. [13]

FDA
article thumbnail

Vamorolone

New Drug Approvals

Syn EuropeanJournalofMedicinalChemistry265(2024)116124 Vamorolone (Agamree) On October 26, 2023, Vamorolone, developed jointly by Santhera Pharmaceuticals and ReveraGen BioPharma, has received FDA approval to treat DMD in patients aged 2 years and older [1]. October 2014). 23] Vamorolone is sold under the brand name Agamree. [1]

FDA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Automated red blood cell exchange: bridging treatment gaps in sickle cell disease care

Drug Target Review

Currently, three FDA-approved disease-modifying drug therapies are available: hydroxyurea, crizanlizumab and L-glutamine, though each has limitations that affect patient compliance. The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease. JAMA Netw Open. 2023 Nov 1;6(11):e2344546.

article thumbnail

PRITELIVIR MESYLATE

New Drug Approvals

7] If the virus also acquires resistance to foscarnet, then there is currently no FDA approved treatment. 2014 Jan 16;370(3):201-10. The use of foscarnet is commonly accompanied by restrictive toxicity, particularly nephrotoxicity. [7] Casalegno, J.S. 111 : 36–41. doi : 10.1016/j.antiviral.2014.08.013. 2014.08.013. Marchaim, D.;

article thumbnail

The science of ageing and restoring healthspan

Drug Target Review

Jerry has over 30 years of experience in the biopharmaceutical industry and has been involved in the discovery, clinical development, and global commercialisation of more than a dozen FDA-approved drugs with multiple successful exits. acquired by Teva Pharmaceuticals in 2014. a commercial stage pharmaceutical company.

article thumbnail

Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS

The Pharma Data

Food and Drug Administration (FDA) approval for the cobas® HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas® 6800/8800 Systems in the U.S. Published 2014 Aug 26. Combines confirmatory HIV testing and HIV-1/HIV-2 differentiation into one single test. Clin Infect Dis. 2011;52(6):780-787. BMC Infect Dis.

article thumbnail

Avacta Announces Collaboration Agreement With Bruker

The Pharma Data

Our objective is to work with Bruker and our clinical partners to deliver an effective and high throughput assay protocol, that can be applied in the clinical setting, with the required sensitivity and specificity and CE/FDA approvals to provide a useful additional diagnostic tool in the fight against the coronavirus. Source link.